A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives

Contraception

Volumn 58, Issue 2, 1998, Pages 75-81

  Aden, Ulrike ^a   Jung Hoffmann, Claudia ^a   Kuhl, Herbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Corticosteroid binding globulin; Gonadotropins, androgens; Sex hormone binding globulin; Sex steroids; Triphasic oral contraceptives

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GONADOTROPIN; LEVONORGESTREL; NORETHISTERONE; PRASTERONE; TESTOSTERONE; TRISISTON;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; ORAL CONTRACEPTION; OVULATION INHIBITION; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; BIOLOGY; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS, ESTROGEN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE METHODS--PHARMACODYNAMICS; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ETHINYL ESTRADIOL--ADMINISTRACTION AND DOSAGE; EUROPE; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; GERMANY; GONADOTROPINS; HORMONES; LEVONORGESTREL--ADMINISTRACTION AND DOSAGE; ORAL CONTRACEPTIVES, COMBINED--PHARMACODYNAMICS; ORAL CONTRACEPTIVES, PHASIC--PHARMACODYNAMICS; ORAL CONTRACEPTIVES--PHARMACODYNAMICS; OVARIAN EFFECTS; OVARY; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; UROGENITAL SYSTEM; WESTERN EUROPE;

ADULT; CARRIER PROTEINS; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; HYDROCORTISONE; PREGNENEDIONES; PROGESTERONE; PROLACTIN;

EID: 0032144535     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00071-7     Document Type: Article

References (20)

1. Kuhl H., Gahn G., Romberg G., März W., Taubert H.D. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters. I. Effects upon sexual hormone levels. Contraception. 31:1985;583-593.
2. Jung-Hoffmann C., Storch A., Kuhl H. Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel. Horm Res. 38:1992;184-189.
3. McGuire J.L., Bariso C.D., Yuliano E., Hume R.J., Pasquale S.A. Effects of low-dose oral contraceptives containing norethindrone and ethinylestradiol on serum levels of progesterone and pituitary gonadotropins. Contraception. 11:1975;329-338.
4. Dericks-Tan J.S.E., Schneider K., Taubert H.D. The mechanism of action of a new low-dosed combined oral contraceptive. Arch Gynecol. 229:1980;107-114.
5. Ling W.Y., Johnston D.W., Lea R.H., Bent A.E., Scott J.Z., Toews M.R. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive. Contraception. 32:1985;367-375.
6. Kim-Björklund T., Landgren B.M., Hamberger L. Is the contraceptive effect of 300 μg norethisterone mainly peripheral or central? Contraception. 45:1992;57-66.
7. Gaspard U.J., Romus M.A., Gillain D., Franchimont P., Duvivier J. Plasma hormone levels in women receiving new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Contraception. 27:1983;577-590.
8. Gaspard U.J., Dubois M., Gillain D., Duvivier J., Demey-Ponsart E., Franchimont P. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Contraception. 29:1984;305-318.
9. Jung-Hoffmann C., Kuhl H. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone. Am J Obstet Gynecol. 156:1987;199-203.
10. Refn H., Kjaer A., Lebech A.M., Borggaard B., Schierup L. Clinical and hormonal effects of two contraceptives correlation to serum concentrations of levonorgestrel and gestodene . Contraception. 41:1990;259-268.
11. van der Vange N., Blankenstein M.A., Kloosterboer H.J., Haspels A.A., Thijssen J.H.H. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception. 41:1990;345-351.
12. Jung-Hoffmann C., Heidt F., Kuhl H. Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parameters. Contraception. 38:1988;593-603.
13. Klove K.L., Roy S., Lobo R.A. The effect of different contraceptive treatments on the serum concentrations of dehydroepiandrosterone sulphate. Contraception. 29:1984;319-324.
14. Wiegratz I., Jung-Hoffmann C., Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception. 51:1995;341-346.
15. Fern M., Rose D.P., Fern E.B. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol. 51:1978;541-544.
16. Padmanabhan V., Lang L.L., Sonstein J., Kelch R.P., Beitins I.Z. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J Clin Endocrinol Metab. 67:1988;465-473.
17. Schleussner E., Börner A., Michels W., Carol W. Effects of the synthetic progestogen desogestrel and the combination of 20 μg ethinylestradiol + 150 μg desogestrel on pulsatile gonadotropin secretion. Exp Clin Endocrinol. 101:(suppl 1):1993;32.
18. Davis J.R.E., Selby C., Jeffcoate C. Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol. 20:1984;427-434.
19. Kuhl H., Jung-Hoffmann C., Weber J., Boehm B.O. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception. 47:1993;55-68.
20. Scott J.Z., Kletzky O.A., Brenner P.F., Mishell D.R. Jr. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Fertil Steril. 30:1978;141-145.